2024-04-012025-03-312025-03-31false14845807NORWICH DENTAL CARE LIMITED2025-10-06falseiso4217:GBPxbrli:pure148458072024-03-31148458072025-03-31148458072024-04-012025-03-31148458072023-05-03148458072024-03-31148458072023-05-042024-03-3114845807bus:SmallEntities2024-04-012025-03-3114845807bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3114845807bus:FullAccounts2024-04-012025-03-3114845807bus:PrivateLimitedCompanyLtd2024-04-012025-03-3114845807core:WithinOneYear2025-03-3114845807core:AfterOneYear2025-03-3114845807core:WithinOneYear2024-03-3114845807core:AfterOneYear2024-03-3114845807core:ShareCapital2025-03-3114845807core:SharePremium2025-03-3114845807core:RevaluationReserve2025-03-3114845807core:OtherReservesSubtotal2025-03-3114845807core:RetainedEarningsAccumulatedLosses2025-03-3114845807core:ShareCapital2024-03-3114845807core:SharePremium2024-03-3114845807core:RevaluationReserve2024-03-3114845807core:OtherReservesSubtotal2024-03-3114845807core:RetainedEarningsAccumulatedLosses2024-03-3114845807core:LandBuildings2025-03-3114845807core:PlantMachinery2025-03-3114845807core:Vehicles2025-03-3114845807core:FurnitureFittings2025-03-3114845807core:OfficeEquipment2025-03-3114845807core:NetGoodwill2025-03-3114845807core:IntangibleAssetsOtherThanGoodwill2025-03-3114845807core:ListedExchangeTraded2025-03-3114845807core:UnlistedNon-exchangeTraded2025-03-3114845807core:LandBuildings2024-03-3114845807core:PlantMachinery2024-03-3114845807core:Vehicles2024-03-3114845807core:FurnitureFittings2024-03-3114845807core:OfficeEquipment2024-03-3114845807core:NetGoodwill2024-03-3114845807core:IntangibleAssetsOtherThanGoodwill2024-03-3114845807core:ListedExchangeTraded2024-03-3114845807core:UnlistedNon-exchangeTraded2024-03-3114845807core:LandBuildings2024-04-012025-03-3114845807core:PlantMachinery2024-04-012025-03-3114845807core:Vehicles2024-04-012025-03-3114845807core:FurnitureFittings2024-04-012025-03-3114845807core:OfficeEquipment2024-04-012025-03-3114845807core:NetGoodwill2024-04-012025-03-3114845807core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3114845807core:ListedExchangeTraded2024-04-012025-03-3114845807core:UnlistedNon-exchangeTraded2024-04-012025-03-3114845807core:MoreThanFiveYears2024-04-012025-03-3114845807core:Non-currentFinancialInstruments2025-03-3114845807core:Non-currentFinancialInstruments2024-03-3114845807dpl:CostSales2024-04-012025-03-3114845807dpl:DistributionCosts2024-04-012025-03-3114845807core:LandBuildings2024-04-012025-03-3114845807core:PlantMachinery2024-04-012025-03-3114845807core:Vehicles2024-04-012025-03-3114845807core:FurnitureFittings2024-04-012025-03-3114845807core:OfficeEquipment2024-04-012025-03-3114845807dpl:AdministrativeExpenses2024-04-012025-03-3114845807core:NetGoodwill2024-04-012025-03-3114845807core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3114845807dpl:GroupUndertakings2024-04-012025-03-3114845807dpl:ParticipatingInterests2024-04-012025-03-3114845807dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3114845807core:ListedExchangeTraded2024-04-012025-03-3114845807dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3114845807core:UnlistedNon-exchangeTraded2024-04-012025-03-3114845807dpl:CostSales2023-05-042024-03-3114845807dpl:DistributionCosts2023-05-042024-03-3114845807core:LandBuildings2023-05-042024-03-3114845807core:PlantMachinery2023-05-042024-03-3114845807core:Vehicles2023-05-042024-03-3114845807core:FurnitureFittings2023-05-042024-03-3114845807core:OfficeEquipment2023-05-042024-03-3114845807dpl:AdministrativeExpenses2023-05-042024-03-3114845807core:NetGoodwill2023-05-042024-03-3114845807core:IntangibleAssetsOtherThanGoodwill2023-05-042024-03-3114845807dpl:GroupUndertakings2023-05-042024-03-3114845807dpl:ParticipatingInterests2023-05-042024-03-3114845807dpl:GroupUndertakingscore:ListedExchangeTraded2023-05-042024-03-3114845807core:ListedExchangeTraded2023-05-042024-03-3114845807dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-05-042024-03-3114845807core:UnlistedNon-exchangeTraded2023-05-042024-03-3114845807core:NetGoodwill2025-03-3114845807core:IntangibleAssetsOtherThanGoodwill2025-03-3114845807core:LandBuildings2025-03-3114845807core:PlantMachinery2025-03-3114845807core:Vehicles2025-03-3114845807core:FurnitureFittings2025-03-3114845807core:OfficeEquipment2025-03-3114845807core:AfterOneYear2025-03-3114845807core:WithinOneYear2025-03-3114845807core:ListedExchangeTraded2025-03-3114845807core:UnlistedNon-exchangeTraded2025-03-3114845807core:ShareCapital2025-03-3114845807core:SharePremium2025-03-3114845807core:RevaluationReserve2025-03-3114845807core:OtherReservesSubtotal2025-03-3114845807core:RetainedEarningsAccumulatedLosses2025-03-3114845807core:NetGoodwill2024-03-3114845807core:IntangibleAssetsOtherThanGoodwill2024-03-3114845807core:LandBuildings2024-03-3114845807core:PlantMachinery2024-03-3114845807core:Vehicles2024-03-3114845807core:FurnitureFittings2024-03-3114845807core:OfficeEquipment2024-03-3114845807core:AfterOneYear2024-03-3114845807core:WithinOneYear2024-03-3114845807core:ListedExchangeTraded2024-03-3114845807core:UnlistedNon-exchangeTraded2024-03-3114845807core:ShareCapital2024-03-3114845807core:SharePremium2024-03-3114845807core:RevaluationReserve2024-03-3114845807core:OtherReservesSubtotal2024-03-3114845807core:RetainedEarningsAccumulatedLosses2024-03-3114845807core:NetGoodwill2023-05-0314845807core:IntangibleAssetsOtherThanGoodwill2023-05-0314845807core:LandBuildings2023-05-0314845807core:PlantMachinery2023-05-0314845807core:Vehicles2023-05-0314845807core:FurnitureFittings2023-05-0314845807core:OfficeEquipment2023-05-0314845807core:AfterOneYear2023-05-0314845807core:WithinOneYear2023-05-0314845807core:ListedExchangeTraded2023-05-0314845807core:UnlistedNon-exchangeTraded2023-05-0314845807core:ShareCapital2023-05-0314845807core:SharePremium2023-05-0314845807core:RevaluationReserve2023-05-0314845807core:OtherReservesSubtotal2023-05-0314845807core:RetainedEarningsAccumulatedLosses2023-05-0314845807core:AfterOneYear2024-04-012025-03-3114845807core:WithinOneYear2024-04-012025-03-3114845807core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3114845807core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3114845807core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3114845807core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3114845807core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3114845807core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3114845807core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3114845807core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3114845807core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3114845807core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3114845807core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3114845807core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3114845807core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3114845807core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3114845807core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3114845807core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3114845807core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3114845807core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3114845807core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3114845807core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3114845807core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3114845807core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3114845807core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3114845807core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3114845807core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3114845807core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3114845807core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3114845807bus:Director12024-04-012025-03-3114845807bus:Director22024-04-012025-03-3114845807core:FurnitureFittingsToolsEquipment2024-03-3114845807core:FurnitureFittingsToolsEquipment2024-04-012025-03-3114845807core:FurnitureFittingsToolsEquipment2025-03-31

NORWICH DENTAL CARE LIMITED

Registered Number
14845807
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

NORWICH DENTAL CARE LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

Mrs Marjan Naeini
Dr Masoud Shahram

Registered Address

Dental Practice
88 Hall Road
Norwich
NR1 3HP

Registered Number

14845807 (England and Wales)
NORWICH DENTAL CARE LIMITED
Statement of Financial Position
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets31,560,0001,560,000
Tangible assets426,7324,079
1,586,7321,564,079
Current assets
Stocks53,4004,173
Debtors18,88924,192
Cash at bank and on hand364,686196,326
386,975224,691
Creditors amounts falling due within one year6(1,466,840)(1,694,847)
Net current assets (liabilities)(1,079,865)(1,470,156)
Total assets less current liabilities506,86793,923
Provisions for liabilities7(6,683)(1,020)
Net assets500,18492,903
Capital and reserves
Called up share capital100100
Profit and loss account500,08492,803
Shareholders' funds500,18492,903
The financial statements were approved and authorised for issue by the Board of Directors on 6 October 2025, and are signed on its behalf by:
Dr Masoud Shahram
Director
Registered Company No. 14845807
NORWICH DENTAL CARE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Functional and presentation currency
The financial statements are presented in sterling, which is the functional currency of the entity.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Turnover policy
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Operating leases
Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Current taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amount of tax expected to pay or recover using the tax rates and laws that have been enacted, or substantively enacted, at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted, or substantively enacted, by the reporting date that are expected to apply to the reversal of the timing difference.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Goodwill
Goodwill arising on an acquisition of a business is carried at cost less accumulated impairment losses, if any. Goodwill is amortised over its expected useful life which is estimated to be ten years. Goodwill is assessed for impairment when there are indicators of impairment and any impairment is charged to the income statement. No reversals of impairment are recognised.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Reducing balance (%)Straight line (years)
Plant and machinery-10
Office Equipment20-
Stocks and work in progress
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all cost of purchase, cost of conversion and other costs incurred in bringing the stock to its present location and condition.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20252024
Average number of employees during the year1111
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 April 241,560,0001,560,000
At 31 March 251,560,0001,560,000
Net book value
At 31 March 251,560,0001,560,000
At 31 March 241,560,0001,560,000
4.Tangible fixed assets

Plant & machinery

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 April 24-3,2351,0954,330
Additions20,2771093,88624,272
At 31 March 2520,2773,3444,98128,602
Depreciation and impairment
At 01 April 24-16289251
Charge for year-6419781,619
At 31 March 25-8031,0671,870
Net book value
At 31 March 2520,2772,5413,91426,732
At 31 March 24-3,0731,0064,079
5.Stocks

2025

2024

££
Raw materials and consumables3,4004,173
Total3,4004,173
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables47,95734,929
Taxation and social security137,13431,122
Other creditors1,242,8961,624,597
Accrued liabilities and deferred income38,8534,199
Total1,466,8401,694,847
7.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)6,6831,020
Total6,6831,020
8.Related party transactions
During the year the directors made available loans to the Company. At the year end the balance of the loan was £1,241,915 (2024: £1,624,090). This loan is interest free and repayable on demand